These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 7675936

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Atrial natriuretic hormone inhibits corticotropin-releasing hormone-induced prolactin release in man.
    Wiedemann K, Herzog L, Kellner M.
    J Psychiatr Res; 1995; 29(1):51-8. PubMed ID: 7629756
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Response of the hypothalamic-pituitary-adrenal axis to small dose arginine-vasopressin and daily urinary free cortisol before and after alprazolam pre-treatment differs in obesity.
    Vicennati V, Ceroni L, Gagliardi L, Pagotto U, Gambineri A, Genghini S, Pasquali R.
    J Endocrinol Invest; 2004 Jun; 27(6):541-7. PubMed ID: 15717651
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Roles of type I and II corticosteroid receptors in regulation of basal activity in the hypothalamo-pituitary-adrenal axis during the diurnal trough and the peak: evidence for a nonadditive effect of combined receptor occupation.
    Bradbury MJ, Akana SF, Dallman MF.
    Endocrinology; 1994 Mar; 134(3):1286-96. PubMed ID: 8119168
    [Abstract] [Full Text] [Related]

  • 8. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans.
    Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV.
    J Clin Endocrinol Metab; 1994 Jul; 79(1):140-4. PubMed ID: 8027217
    [Abstract] [Full Text] [Related]

  • 9. Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum.
    Mastorakos G, Ilias I.
    Ann N Y Acad Sci; 2003 Nov; 997():136-49. PubMed ID: 14644820
    [Abstract] [Full Text] [Related]

  • 10. Hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin-releasing factor/arginine-vasopressin test and of stress.
    Pasquali R, Anconetani B, Chattat R, Biscotti M, Spinucci G, Casimirri F, Vicennati V, Carcello A, Labate AM.
    Metabolism; 1996 Mar; 45(3):351-6. PubMed ID: 8606643
    [Abstract] [Full Text] [Related]

  • 11. Atrial natriuretic hormone decreases endocrine response to a combined dexamethasone-corticotropin-releasing hormone test.
    Ströhle A, Kellner M, Holsboer F, Wiedemann K.
    Biol Psychiatry; 1998 Mar 01; 43(5):371-5. PubMed ID: 9513753
    [Abstract] [Full Text] [Related]

  • 12. Corticotropin-releasing hormone and the sympathoadrenal system are major mediators in the effects of peripherally administered exendin-4 on the hypothalamic-pituitary-adrenal axis of male rats.
    Gil-Lozano M, Romaní-Pérez M, Outeiriño-Iglesias V, Vigo E, González-Matías LC, Brubaker PL, Mallo F.
    Endocrinology; 2014 Jul 01; 155(7):2511-23. PubMed ID: 24731096
    [Abstract] [Full Text] [Related]

  • 13. Late feedback effects of hypothalamic-pituitary-adrenal axis hormones in healthy subjects.
    Posener JA, Schildkraut JJ, Williams GH, Schatzberg AF.
    Psychoneuroendocrinology; 1998 May 01; 23(4):371-83. PubMed ID: 9695137
    [Abstract] [Full Text] [Related]

  • 14. Influence of exogenous atrial natriuretic peptide on the pituitary-adrenal response to corticotropin-releasing hormone and vasopressin in healthy men.
    Bierwolf C, Burgemeister A, Lüthke K, Born J, Fehm HL.
    J Clin Endocrinol Metab; 1998 Apr 01; 83(4):1151-7. PubMed ID: 9543132
    [Abstract] [Full Text] [Related]

  • 15. Effect of plasma osmolality on pituitary-adrenal responses to corticotropin-releasing hormone and atrial natriuretic peptide changes in central diabetes insipidus.
    Elias LL, Antunes-Rodrigues J, Elias PC, Moreira AC.
    J Clin Endocrinol Metab; 1997 Apr 01; 82(4):1243-7. PubMed ID: 9100602
    [Abstract] [Full Text] [Related]

  • 16. Influence of exogenous atrial natriuretic peptide on the nocturnal hypothalamic-pituitary-adrenal axis and sleep in healthy men.
    Demiralay C, Jahn H, Kellner M, Yassouridis A, Wiedemann K.
    Psychoneuroendocrinology; 2010 Nov 01; 35(10):1438-45. PubMed ID: 20554120
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of pituitary-adrenal secretion by a corticotropin releasing hormone antagonist in humans.
    Baram TZ, Mitchell WG, Haden E.
    Mol Psychiatry; 1996 Sep 01; 1(4):320-4. PubMed ID: 9118358
    [Abstract] [Full Text] [Related]

  • 18. Hypothalamo-pituitary-adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration: sex differences between major depressives and matched control subjects.
    Rubin RT, O'Toole SM, Rhodes ME, Sekula LK, Czambel RK.
    Psychiatry Res; 1999 Dec 13; 89(1):1-20. PubMed ID: 10643873
    [Abstract] [Full Text] [Related]

  • 19. Combined hypervolemia and hypoosmolality alter hypothalamic-pituitary-adrenal axis response to endotoxin stimulation.
    Dadoun F, Velut JG, Guillaume V, Sauze N, Orsoni JC, Gaillard RC, Oliver CC.
    Neuroendocrinology; 1999 May 13; 69(5):352-9. PubMed ID: 10343176
    [Abstract] [Full Text] [Related]

  • 20. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
    Thomas GB, Fairhall KM, Robinson IC.
    Endocrinology; 1997 Apr 13; 138(4):1585-91. PubMed ID: 9075719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.